Immune role of CD14+ & CD14- human skin dendritic cells
Immune role of CD14+ & CD14- human skin dendritic cells
批准号:
6712216
负责人:
Adriana T Larregina
金额:
$22.29万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2006-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Peripheral tissue-resident dendritic cells (DCs) are professional antigen (Ag) presenting cells (APCs) that initiate primary T cell immune responses. To achieve this, they: i) take up and process Ags; ii) migrate from periphery to draining lymph nodes; and iii) prime naive T cells. Besides their potent T cell stimulatory function, peripheral tissue resident-DCs play a key role in maintenance of peripheral tolerance in steady-state conditions. A crucial step for initiation of immunity or tolerance is the priming and biasing of naive CD4 T cells into T helper (Th) 1 cells (cellular immune response), Th2 cells (humoral immunity) or regulatory T cells (TR) (tolerance). Activation and biasing of naive CD4 T cells by DCs are determined mainly by: i) the characteristics of the DC-T cell synapse, and ii) the pattern of cytokines secreted by DCs during DC-T cell contact. The level of T cell stimulatory molecules on the DC surface and the pattern DC cytokines are influenced greatly by the characteristics of the stimuli (danger signals) during activation of DCs in peripheral tissues. As examples, activation of skin DCs by dinitrocholorobenzene (DNCB) induces a prevalent Th1 response, DC-activation by FITC generates a Th2-biased response and skin UV-B irradiation favors tolerance. Conversely, it is still not clear the nature of the stimuli that trigger steady migration of DCs from periphery in the absence of tissue damage. Moreover, the mechanisms involved in the initiation of T cell responses by peripheral tissue resident DCs have not been analyzed in humans. To address these questions a model of ex-vivo human skin explants that permits to analyze the T cell stimulatory function of different types of skin migratory (smi) DCs and the effect that immunostimulatorv (danger signals) or tolerogenic stimuli may exert on cutaneous DCs would be ideal. We and others have previously identified, based on the expression of the molecule CD14, two populations of skin migratory (smi)DCs: i) smiCD14- DCs, that exhibit phenotype of mature APCs and strong naive T cell stimulatory ability; and ii)smiCD14+ DCs, with a more immature APC phenotype and weak stimulators of naive T cells. In the present We propose to: 1) Compare the immune functions of smiCD14+DCs and smiCD14-DCs spontaneously mobilized from human skin explants, and 2) Determine activation and function of smiCD14+DCs and smiCD14-DCs from epidermal/dermal explants exposed to DNCB (a Th1-biasing sensitizer), FITC (a Th2-biasing sensitizer) or UV-B irradiation (TR-driving stimulus).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of neurokinin 1 receptor signaling in keratinocytes in allergic contact dermatitis
-
批准号:10581825
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2022
-
负责人:Adriana T Larregina
-
依托单位:
Role of neurokinin 1 receptor signaling in keratinocytes in allergic contact dermatitis
-
批准号:10707217
-
项目类别:
-
资助金额:$59.56万
-
财政年份:2022
-
负责人:Adriana T Larregina
-
依托单位:
Use of Substance P antagonists to regulate the skin immune function
-
批准号:8486370
-
项目类别:
-
资助金额:$34.89万
-
财政年份:2009
-
负责人:Adriana T Larregina
-
依托单位:
Use of Substance P antagonists to regulate the skin immune function
-
批准号:8289511
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2009
-
负责人:Adriana T Larregina
-
依托单位:
Use of Substance P antagonists to regulate the skin immune function
-
批准号:7726347
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2009
-
负责人:Adriana T Larregina
-
依托单位:
Use of Substance P antagonists to regulate the skin immune function
-
批准号:8078942
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2009
-
负责人:Adriana T Larregina
-
依托单位:
Use of Substance P antagonists to regulate the skin immune function
-
批准号:7872833
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Adriana T Larregina
-
依托单位:
Use of Adjuvants to Improve Skin Genetic Immunizations
-
批准号:7409594
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
Immune role of CD14+ & CD14- human skin dendritic cells
-
批准号:6877157
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
Use of Adjuvants to Improve Skin Genetic Immunizations
-
批准号:6858587
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
Use of Adjuvants to Improve Skin Genetic Immunizations
-
批准号:7189825
-
项目类别:
-
资助金额:$25.64万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
Use of Adjuvants to Improve Skin Genetic Immunizations
-
批准号:7008842
-
项目类别:
-
资助金额:$26.41万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
Use of Adjuvants to Improve Skin Genetic Immunizations
-
批准号:6721071
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2004
-
负责人:Adriana T Larregina
-
依托单位:
海外基金